ARTICLE | Management Tracks
Plus: Sirnaomics promotes Lebel to CMO and updates from Enavate Sciences, Avoro Ventures, Eagle, Calliditas, 20Med
By Jeff Cranmer, Executive Editor, and Gunjan Ohri, Data Content Analyst
December 1, 2023 11:56 PM UTC
Eliot Forster became CEO of Levicept Ltd. Forster was CEO of F-star Biotechnology Ltd. and Immunocore Holdings plc (NASDAQ:IMCR). He succeeds Simon Westbrook, the U.K.-based chronic pain company’s founder, who will become CSO.
RNAi therapeutics company Sirnaomics Ltd. (HKEX:2257) promoted Francois Lebel to CMO from SVP for preclinical and clinical development. In his new role, Lebel will oversee clinical development of Phase II program, STP705, for squamous cell carcinoma in situ. Before joining the cross-border biotech in July, Lebel was EVP of R&D and CMO of Spectrum Pharmaceuticals Inc. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/650787/eliot-forster-named-levicept-ceo